陈年茯砖茶对高脂血症小鼠的调脂作用

柯菀萍; 刘振云; 李孟华; 周汐芮; 郭晓莉; 张盛; 黄建安; 刘仲华; 肖力争; 林勇

doi:10.13305/j.cnki.jts.2024.04.008

PDF(1448 KB)

茶叶科学 ›› 2024, Vol. 44 ›› Issue (4) : 683-693. DOI: 10.13305/j.cnki.jts.2024.04.008

研究报告

陈年茯砖茶对高脂血症小鼠的调脂作用

柯菀萍^1,2, 刘振云^1,2, 李孟华^1,2, 周汐芮^1,2, 郭晓莉^1,2, 张盛^2,3, 黄建安^1,2,3, 刘仲华^1,2,3, 肖力争^2,3,*, 林勇^1,2,3,*

作者信息 +

Alleviative Effects of Aged Fu Brick Tea on Lipid Metabolism in Hyperlipidemic Mice

KE Wanping^1,2, LIU Zhenyun^1,2, LI Menghua^1,2, ZHOU Xirui^1,2, GUO Xiaoli^1,2, ZHANG Sheng^2,3, HUANG Jian′an^1,2,3, LIU Zhonghua^1,2,3, XIAO Lizheng^2,3,*, LIN Yong^1,2,3,*

Author information +

文章历史 +

摘要

为探究不同年份茯砖茶对高脂饮食诱导的肥胖及高脂血症的预防效果,以C57BL/6J小鼠为研究对象,以陈化1年和10年的茯砖茶为代表性茶样,设置了正常饮食（ND）组,高脂饮食（HFD）组,以及陈化1年茯砖茶干预（1Y）组和陈化10年茯砖茶干预（10Y）组。生物活性成分分析发现,陈化10年茯砖茶中的茶褐素、可溶性糖含量明显增加,而多酚和儿茶素单体明显下降。动物实验结果表明,与HFD组相比,陈化1年和陈化10年的茯砖茶能够有效降低小鼠肝脏和血清脂质水平、体重增长、器官系数和脂肪组织重量,且陈化10年的茯砖茶具有相对显著的效果。小鼠肝脏和脂肪组织切片显示,补充茯砖茶可以减少肝脏中脂滴的形成和空泡的出现,同时抑制了脂肪细胞的膨大。此外,补充茯砖茶能够改善高脂饮食导致的炎症和肝脏氧化应激,与陈化1年的茯砖茶相比,陈化10年的茯砖茶显著降低了炎症因子IL-6和TNF-α水平以及肝损伤指标AST和ALT活力,同时显著上调了肝脏GSH含量（P<0.05）。这可能是由于陈化10年茯砖茶丰富的茶褐素以及与其他活性成分共同作用的结果。

Abstract

To investigate the preventive effect of Fu brick tea with different years on high-fat diet-induced obesity and hyperlipidemia, this experiment was conducted with C57BL/6J mice, and Fu brick tea aged for 1 and 10 years were used as representative tea samples. The normal diet group (ND), high-fat diet group (HFD), and Fu brick tea with different ageing time (10Y, 1Y) were set up. The analysis of bioactive components of the tea samples reveals a significant increase in the contents of theabrownin and soluble sugars, and a significant decrease in polyphenols and catechin monomers in Fu brick tea aged for 10 years. Animal test results show that Fu brick tea aged for 1 year and 10 years were effective in reducing liver and serum lipid levels, body weight gain, organ coefficients and adipose tissue weights compared to the HFD group, and that Fu brick tea aged for 10 years had a relatively significant effect. Liver and adipose tissue sections show that Fu brick tea supplementation reduced the formation of lipid droplets and the appearance of vacuoles in the liver, as well as inhibited adipocyte expansion. In addition, Fu brick tea supplementation ameliorated inflammation and hepatic oxidative stress caused by a high-fat diet. Compared with Fu brick tea aged for 1 year, Fu brick tea aged for 10 years significantly reduced the levels of the inflammatory factors IL-6 and TNF-α, as well as the liver injury indicators (AST and ALT viabilities), while significantly up-regulating the hepatic GSH content (P<0.05). This may be a result of the richness of theabrownin in 10-year aged Fu brick tea and its co-action with other active ingredients.

导出引用

柯菀萍, 刘振云, 李孟华, 周汐芮, 郭晓莉, 张盛, 黄建安, 刘仲华, 肖力争, 林勇. 陈年茯砖茶对高脂血症小鼠的调脂作用[J]. 茶叶科学. 2024, 44(4): 683-693 https://doi.org/10.13305/j.cnki.jts.2024.04.008

KE Wanping, LIU Zhenyun, LI Menghua, ZHOU Xirui, GUO Xiaoli, ZHANG Sheng, HUANG Jian′an, LIU Zhonghua, XIAO Lizheng, LIN Yong. Alleviative Effects of Aged Fu Brick Tea on Lipid Metabolism in Hyperlipidemic Mice[J]. Journal of Tea Science. 2024, 44(4): 683-693 https://doi.org/10.13305/j.cnki.jts.2024.04.008

中图分类号： S571.1 R972+.6

参考文献

[1] Dembowski E, Freedman I, Grundy S M, et al.Guidelines for the management of hyperlipidemia: how can clinicians effectively implement them?[J]. Progress in Cardiovascular Diseases, 2022, 75: 4-11.
[2] Aguilar-Salinas C A, Gómez-Díaz R A, Corral P. New therapies for primary hyperlipidemia[J]. The Journal of Clinical Endocrinology and Metabolism, 2022, 107(5): 1216-1224.
[3] Buldak Ł, Marek B, Kaidaniuk D, et al.Endocrine diseases as causes of secondary hyperlipidemia[J]. Endokrynologia Polska, 2019, 70(6): 511-519.
[4] El-Tantawy W H, Temraz A. Natural products for controlling hyperlipidemia: review[J]. Archives of Physiology and Biochemistry, 2018, 125(2): 128-135.
[5] Song D X, Jiang J G.Hypolipidemic components from medicine food homology species used in China: pharmacological and health effects[J]. Archives of Medical Research, 2017, 48(7): 569-581.
[6] Chen G, Wang H, Zhang X, et al.Nutraceuticals and functional foods in the management of hyperlipidemia[J]. Critical Reviews in Food Science and Nutrition, 2014, 54(9): 1180-1201.
[7] Chen G, Peng Y, Xie M, et al.A critical review of Fuzhuan brick tea: processing, chemical constituents, health benefits and potential risk[J]. Critical Reviews in Food Science and Nutrition, 2021, 63(22): 5447-5464.
[8] Liu D, Wang S, Liu Y, et al.Fuzhuan brick tea ameliorates hepatic steatosis and steatohepatitis through gut microbiota-derived aryl hydrocarbon receptor ligands in high-fat diet-induced obese mice[J]. Food and Function, 2023, 14(18): 8351-8368.
[9] 李秀平, 欧阳建, 唐静怡, 等. 茯砖茶通过调节肠道菌群和胆汁酸代谢预防肥胖及高胆固醇血症作用机制[J]. 食品科学, 2022, 43(9): 136-149.
Li X P, Ouyang J, Tang J Y, et al.Fuzhuan brick tea prevents obesity and hypercholesterolemia by regulating the intestinal flora and bile acid metabolism[J]. Food Science, 2022, 43(9): 136-149.
[10] Du H, Shi L, Yan T, et al.Fu brick tea protects against high-fat diet-induced obesity phenotypes via promoting adipose browning and thermogenesis in association with gut microbiota[J]. Food and Function, 2022, 13(21): 11111-11124.
[11] Liu D, Wang J, Zeng H, et al.The metabolic regulation of Fuzhuan brick tea in high-fat diet-induced obese mice and the potential contribution of gut microbiota[J]. Food and Function, 2022, 13(1): 356-374.
[12] 敬娜娜, 田丹, 蓝海芳, 等. 茯砖茶水提物对高脂饮食诱导肥胖小鼠肝脏脂质代谢的影响[J]. 食品科技, 2019, 44(11): 232-237.
Jing N N, Tian D, Lan H F, et al.Effect of Fu brick tea extracts on lipid metabolism in liver of obese mice induced by high-fat diet[J]. Food Science and Technology, 2019, 44(11): 232-237.
[13] 张文将, 刘圆月, 范文涛, 等. 茯砖茶对APOE-/-小鼠肝脂合成和氧化应激影响[J]. 食品与生物技术学报, 2021, 40(3): 103-111.
Zhang W J, Liu Y Y, Fan W T, et al.Effects of Fuzhuan tea on liver lipid synthesis and oxidative stress in APOE-/- mice[J]. Journal of Food and Biotechnology, 2021, 40(3): 103-111.
[14] 黄景源. 陈放时间对茯砖茶抗氧化性的影响研究[J]. 食品研究与开发, 2016, 37(3): 52-55.
Huang J Y.Study on the effect of ageing time on the antioxidant property of Fuzhuan tea[J]. Food Research and Development, 2016, 37(3): 52-55.
[15] Du H, Shi L, Wang Q, et al.Fu brick tea polysaccharides prevent obesity via gut microbiota-controlled promotion of adipocyte browning and thermogenesis[J]. Journal of Agricultural and Food Chemistry, 2022, 70(43): 13893-13903.
[16] Zhou F, Li Y L, Zhang X, et al.Polyphenols from Fu brick tea reduce obesity via modulation of gut microbiota and gut microbiota-related intestinal oxidative stress and barrier function[J]. Journal of Agricultural and Food Chemistry, 2021, 69(48): 14530-14543.
[17] Wang Y, Zhao A, Du H, et al.Theabrownin from Fu brick tea exhibits the thermogenic function of adipocytes in high-fat-diet-induced obesity[J]. Journal of Agricultural and Food Chemistry, 2021, 69(40): 11900-11911.
[18] Chen G, Xie M, Wan P, et al.Fuzhuan brick tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota[J]. Journal of Agricultural and Food Chemistry, 2018, 66(11): 2783-2795.
[19] 余智勇. 茯砖茶抗腹泻作用研究[D]. 长沙: 湖南农业大学, 2010.
Yu Z Y.Inhibitory effects of Fuzhuan tea on drug-induced diarrhoea in mice [D]. Changsha: Hunan Agricultural University, 2010.
[20] 傅冬和, 余智勇, 黄建安, 等. 不同年份茯砖茶水提取物的抑菌效果研究[J]. 中国茶叶, 2011, 33(1): 10-12.
Fu D H, Yu Z Y, Huang J A, et al.Bacteriostatic effects of aqueous extracts of Fu brick tea from different years[J]. China Tea, 2011, 33(1): 10-12.
[21] Yuan E, Duan X, Xiang L, et al.Aged Oolong tea reduces high-fat diet-induced fat accumulation and dyslipidemia by regulating the AMPK/ACC signaling pathway[J]. Nutrients, 2018, 10(2): 187. doi: 10.3390/nu10020187.
[22] Fang W W, Wang K F, Zhou F, et al.Oolong tea of different years protects high-fat diet-fed mice against obesity by regulating lipid metabolism and modulating the gut microbiota[J]. Food and Function, 2023, 14(6): 2668-2683.
[23] 李适, 谌滢, 傅冬和, 等. 不同年份茯砖茶感官品质研究[J]. 茶叶科学, 2016, 36(5): 500-504.
Li S, Zhan Y, Fu D H, et al.Sensory quality of Fuzhuan tea of different years[J]. Journal of Tea Science, 2016, 36(5): 500-504.
[24] 陆英, 陈金华, 钟晓红, 等. 不同年份茯砖茶的挥发性成分差异[J]. 湖南农业大学学报(自然科学版), 2016, 42(2): 186-192.
Lu Y, Chen J H, Zhong X H, et al.Differences in volatile components of Fuzhuan tea of different years[J]. Journal of Hunan Agricultural University (Natural Science Edition), 2016, 42(2): 186-192.
[25] 林勇, 刘仲华, 林海燕, 等. 茯砖茶水提物对高脂血症小鼠脂质代谢的影响及其抗氧化作用的研究[J]. 食品安全质量检测学报, 2015, 6(5): 1561-1566.
Lin Y, Liu Z H, Lin H Y, et al.Effects of aqueous extract of Poria cocos tea on lipid metabolism and its antioxidant effects in hyperlipidaemic mice[J]. Journal of Food Safety and Quality Inspection, 2015, 6(5): 1561-1566.
[26] 张文将, 刘柏炎, 陈雪梅, 等. 茯砖茶对高脂血症APOE-/-小鼠瘦素抵抗的影响[J]. 湖南中医杂志, 2023, 39(12): 135-141.
Zhang W J, Liu B Y, Chen X M, et al.Effects of Fuzhuan tea on leptin resistance in hyperlipidaemic APOE-/- mice[J]. Hunan Journal of Traditional Chinese Medicine, 2023, 39(12): 135-141.
[27] Li Q, Liu Z H, Huang J A, et al.Anti-obesity and hypolipidemic effects of Fuzhuan brick tea water extract in high-fat diet-induced obese rats[J]. Journal of the Science of Food and Agriculture, 2013, 93(6): 1310-1316.
[28] Litwin M, Kulaga Z.Obesity, metabolic syndrome, and primary hypertension[J]. Pediatric Nephrology, 2020, 36(4): 825-837.
[29] Romero Funes D, Gutierrez Blanco D, Botero-Fonnegra C, et al.Bariatric surgery decreases the number of future hospital admissions for diastolic heart failure in subjects with severe obesity: a retrospective analysis of the US national inpatient sample database[J]. Surgery for Obesity and Related Diseases, 2022, 18(1): 1-8.
[30] Villeneuve T, Guilieminault L.Asthme and obesity in adults[J]. Revue des Maladies Respiratoires, 2020, 37(1): 60-74.
[31] Chao A M, Quigley K M, Wadden T A.Dietary interventions for obesity: clinical and mechanistic findings[J]. Journal of Clinical Investigation, 2021, 131(1): e140065. doi: 10.1172/JCI140065.
[32] Xiong C, Liu C, Pan W, et al.Non-destructive determination of total polyphenols content and classification of storage periods of Iron Buddha tea using multispectral imaging system[J]. Food Chemistry, 2015, 176: 130-136.
[33] 黄亚辉, 陈建华, 周筠, 等. 不同年代茯砖茶感官品质和化学成分的差异性[J]. 食品科学, 2010, 31(2): 228-232.
Huang Y H, Chen J H, Zhou Y, et al.Difference in sensory quality and chemical composition of Fuzhuan tea in different ages[J]. Food Science, 2010, 31(2): 228-232.
[34] 李祥龙, 李晓梅, 杨煦, 等. 黑茶茶褐素与茶多糖对脂肪酶的抑制作用[J]. 食品与机械, 2018, 34(3): 27-31, 58.
Li X L, Li X M, Yang X, et al.Study of inhibition of dark tea theabrownin and tea polysaccharides on lipase[J]. Food and Machinery, 2018, 34(3): 27-31, 58.
[35] 杨玉珠. 茯砖茶多糖提取方法及调脂保肝作用研究[D]. 长沙: 湖南农业大学, 2023.
Yang Y Z.Study on extraction method of polysaccharide from Fuzhuan tea and its effect on regulating lipid and protecting liver [D]. Changsha: Hunan Agricultural University, 2023.
[36] Monteiro J, Alves M G, Oliveira P F, et al.Pharmacological potential of methylxanthines: retrospective analysis and future expectations[J]. Critical Reviews in Food Science and Nutrition, 2019, 59(16): 2597-2625.
[37] Liu T T, Liu X T, Huang G L, et al.Theophylline extracted from Fu brick tea affects the metabolism of preadipocytes and body fat in mice as a pancreatic lipase inhibitor[J]. International Journal of Molecular Sciences, 2022, 23(5): 2525. doi: 10.3390/ijms23052525.
[38] Chen R, Lai X, Xiang L, et al.Aged green tea reduces high-fat diet-induced fat accumulation and inflammation via activating the AMPK-activated protein kinase signaling pathway[J]. Food Nutrition Research, 2022, 66: 7923. doi: 10.29219/fnr.v66.7923.
[39] Koenen M, Hill M A, Cohen P, et al.Obesity, adipose tissue and vascular dysfunction[J]. Circulation Research, 2021, 128(7): 951-968.
[40] Dludla P, Nkambule B, Jack B, et al.Inflammation and oxidative stress in an obese state and the protective effects of gallic acid[J]. Nutrients, 2018, 11(1): 23. doi: 10.3390/nu11010023.
[1] Tanaka T, Narazaki M, Kishmoto T.IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harbor Perspectives in Biology, 2014, 6(10): a016295. doi: 10.1101/cshperspect.a016295.
[2] Sethi J K, Hotamisligil G S.Metabolic messengers: tumour necrosis factor[J]. Nature Metabolism, 2021, 3(10): 1302-1312.